Skip to main content

Advertisement

SpringerLink
Log in

ASO Author Reflections: Can the Total Tumor Volume be an Indicator for Optimal Treatment Strategy in Patients with Colorectal Liver Metastases?

  • ASO Author Reflections
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Yamamoto M, Yoshida M, Furuse J, et al. Clinical practice guidelines for the management of liver metastases from extrahepatic primary cancers 2021. J Hepatobiliary Pancreat Sci. 2021;28:1–25.

    Article  CAS  PubMed  Google Scholar 

  2. Hackl C, Neumann P, Gerken M, Loss M, Klinkhammer-Schalke M, Schlitt HJ. Treatment of colorectal liver metastases in Germany: a ten-year population-based analysis of 5772 cases of primary colorectal adenocarcinoma. BMC Cancer. 2014;14:810.

    Article  PubMed  PubMed Central  Google Scholar 

  3. Tsai CH, Lin CM, Hsieh CC, Hsu WH, Wang HW, Wang LS. Tumor volume is a better prognostic factor than greatest tumor diameter in stage Ia non-small cell lung cancer. Thorac Cardiovasc Surg. 2006;54:537–43.

    Article  PubMed  Google Scholar 

  4. Tai K, Komatsu S, Sofue K, et al. Total tumour volume as a prognostic factor in patients with resectable colorectal cancer liver metastases. BJS Open. 2020;4:456–66.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Shimura Y, Komatsu S, Fukumoto T, et al. The usefulness of total tumor volume as a prognostic factor and in selecting the optimal treatment strategy of chemotherapeutic intervention in patients with colorectal liver metastases. Ann Surg Oncol. 2023. https://doi.org/10.1245/s10434-023-13746-3.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Hepato-Biliary-Pancreatic Surgery, Department of Surgery, Kobe University Graduate School of Medicine, Kobe, Hyogo, Japan

    Yuhi Shimura MD, Shohei Komatsu MD, PhD & Takumi Fukumoto MD, PhD

  2. Department of Medical Oncology/Hematology, Kobe University Graduate School of Medicine, Kobe, Hyogo, Japan

    Hironobu Minami MD, PhD

Authors
  1. Yuhi Shimura MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Shohei Komatsu MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Hironobu Minami MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Takumi Fukumoto MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Shohei Komatsu MD, PhD.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Shimura, Y., Komatsu, S., Minami, H. et al. ASO Author Reflections: Can the Total Tumor Volume be an Indicator for Optimal Treatment Strategy in Patients with Colorectal Liver Metastases?. Ann Surg Oncol 30, 6611–6612 (2023). https://doi.org/10.1245/s10434-023-13870-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-023-13870-0

Search

Navigation